Corrigendum: Development of new approach methods for the identification and characterization of endocrine metabolic disruptors—a PARC project(Front. Toxicol., (2023), 5, (1212509), 10.3389/ftox.2023.1212509)

Abstract

In the published article, there was an error. In Section 5 an erroneous entry was introduced, indicating an opposite effect of what was shown in the reference referring to that entry. A correction has been made to ‘5 Measures for obesogenic effects of MDCs’, paragraph 2. This sentence previously started: “In contrast, in human bone marrow-derived mesenchymal stem cells (hMSCs), BPA alternatives attenuated adipogenesis (Norgren et al., 2022), stressing the importance to research mechanisms and variable exposure scenarios.” The corrected sentence appears below: “In contrast, in human bone marrow-derived mesenchymal stem cells (hMSCs), BPA alternatives induced adipogenesis (Norgren et al., 2022), stressing the importance to research mechanisms and variable exposure scenarios.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.